Identification | Back Directory | [Name]
SHP-141 | [CAS]
946150-57-8 | [Synonyms]
SHP-141 Remetinostat REMETINOSTAT (SHP-141) 4-(7-hydroxycarbamoylheptanoyloxy)benzoic acid methyl ester Benzoic acid, 4-[[8-(hydroxyamino)-1,8-dioxooctyl]oxy]-, methyl ester | [Molecular Formula]
C16H21NO6 | [MDL Number]
MFCD28986227 | [MOL File]
946150-57-8.mol | [Molecular Weight]
323.34 |
Hazard Information | Back Directory | [Uses]
Remetinostat (SHP-141) is a hydroxamic acid-based inhibitor of histone deacetylase enzymes (HDAC) which is under development for the treatment of cutaneous T-cell lymphoma[1]. | [References]
[1] Yijun Deng, et al. Process Development of the Soft Histone Deacetylate Enzyme Inhibitor SHP-141: Acylation of Methyl Paraben and Suberyl Hydroxamic Acid Formation. Org. Process Res. Dev. 2016, 20, 10, 1812-1820. |
|
Company Name: |
InvivoChem
|
Tel: |
13549236410 |
Website: |
https://www.invivochem.cn/ |
Company Name: |
mahaloong
|
Tel: |
+86-028-81192082 +86-18180560816 |
Website: |
https://www.mahaloong.com |
|